Home > Boards > US OTC > Biotechs >

Anteris Technologies Ltd. (AMEUF)

AMEUF RSS Feed
Add AMEUF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/29/2020 4:55:00 PM - Followers: 2 - Board type: Free - Posts Today: 0

Admedus Corp. is the American arm of Australian ASX-listed Admedus Ltd – a diversified healthcare company focused on developing and commercializing next generation technologies with global potential. Specifically, Admedus is developing a new generation of tissue bio-implants that more easily integrate into recipient tissue, show less capacity for rejection and have the potential to replace many of the products that surgeons currently use. Our patented ADAPT™ tissue engineering process produces implantable biological scaffolds that more closely mimic the characteristics of normal human tissue. This promotes a more tolerant immune response with improved tissue in-growth. Tissue exposed to the ADAPT™ process has been shown to have significantly improved functionality and longer term durability of the resulting bio-implant. With the potential for a product lifespan free from calcification, clinicians may be able to intervene across a broader age spectrum and provide their patients with a solution for life.
AMEUF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#1   Admedus Ltd. changed to Anteris Technologies Ltd. Renee 05/29/20 04:55:00 PM
PostSubject
Consent Preferences